Company

Ergomed plc

Headquarters: Guildford, United Kingdom

Employees: 1,150

LSE: ERGO

Market Cap

£494.1 Million

GBP as of July 1, 2023

US$627.8 Million

Market Cap History

Ergomed plc market capitalization over time

Evolution of Ergomed plc market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Ergomed plc

Detailed Description

Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, Rest of Europe, the Middle East, Africa, North America, Asia, and Australia. It operates through two segments, Clinical Research Outsourcing and Pharmacovigilance. The company provides and manages clinical development, post-approval management, and pharmacovigilance services for pharmaceutical and generics companies, as well as small and mid-sized drug development companies. It focuses on various therapeutic areas, including oncology, haematology, allergy, respiratory, and neurology/CNS, as well as develops orphan drugs. The company also provides site support services. The company was formerly known as Ergomed Clinical Research Limited and changed its name to Ergomed plc in June 2014. Ergomed plc was founded in 1997 and is headquartered in Guildford, the United Kingdom.

Top 1-year algo backtest: +287.69%

$10,000 in March 2023 would now be $38,769 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

Ergomed plc has the following listings and related stock indices.


Stock: LSE: ERGO wb_incandescent

Stock: FSX: 2EM wb_incandescent

Stock: XETR: 2EM wb_incandescent

Details

Headquarters:

The Surrey Research Park

1 Occam Court

Guildford, GU2 7HJ

United Kingdom

Phone: 44 1483 503 205

Fax: 44 1483 307 929